The market is pricing the stock in line with historical averages, assuming steady-state growth.
Moderate quality score of 58/100, reflecting stable operating margins and manageable leverage.
Wall Street forecasts a balanced outlook with consensus price targets near the current price.
Verdict: Average quality business weighed down by significant solvency concerns.
Wall Street sentiment is generally neutral. This outlook is strongly supported by highly attractive capital returns, driven by a balanced mix of reliable dividends and share buybacks.
CPT demonstrates adequate business quality with stable profitability. However, the balance sheet carries elevated leverage, requiring careful monitoring of debt servicing capabilities.
The company exhibits steady, low-single-digit revenue growth however, earnings have severely contracted over the same period. The company maintains healthy operational efficiency with a 18.1% operating margin.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | +1.9% | +3.4% | +8.6% | +5.8% | |
| EBITDA | $191.5M | — | +2.4% | — | — | |
| Net Income | $42.4M | +135.4% | -16.2% | — | +4.4% | |
| EPS (Diluted) | $0.40 | +136.0% | -16.3% | +23.3% | +2.5% | |
| Free Cash Flow | -$41.8M | +1.3% | +9.4% | +33.2% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 61.3% | 61.6% | 61.7% | 61.1% |
| Operating Margin | 18.1% | 19.5% | 19.4% | 22.0% |
| Net Margin | 32.8% | 20.4% | 26.7% | 29.9% |
| FCF Margin | 60.4% | 24.7% | 21.6% | 17.3% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $0.28 | $1.70 | +504.1% | ||
| Q1'26 | $0.34 | $1.76 | +415.5% | ||
| Q4'25 | $0.29 | $1.70 | +483.8% | ||
| Q3'25 | $0.33 | $1.70 | +408.7% | ||
| Q2'25 | $0.36 | $1.72 | +379.4% | ||
| Q1'25 | $0.36 | $1.73 | +378.2% | ||
| Q4'24 | $0.36 | $1.71 | +373.0% | ||
| Q3'24 | $0.37 | $1.71 | +361.4% |
Total return is -2.1% (1Y), lagging the benchmark by -27.1%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | -0.1% | -9.4% | — |
| 1Y | -2.1% | -27.1% | +3.6% |
| 3YCAGR | +2.8% | -16.6% | +11.1% |
| 5YCAGR | -0.6% | -13.3% | +14.8% |
| 10YCAGR | +5.9% | -7.6% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Camden Property Trust (CPT) valuation, health, and returns.
Camden Property Trust is estimated to be fair under our discounted cash flow framework. relative multiples indicate the stock is Fair versus peers compared to industry peers. trading near fair value (DCF: $114.00)
Camden Property Trust has multiple valuation anchors: DCF Intrinsic Value: $114.00 | Peer Relative Fair Value: $104.18 | Wall Street Analyst Target: $111.89 (implying +2.7% upside). A convergence of these signals offers higher conviction.
Camden Property Trust displays fair financial health with a composite quality score of 58/100, supported by a Piotroski F-Score of 7/9, Return on Invested Capital (ROIC) of 2.6%.
Camden Property Trust pays a 3.9% dividend yield, covered by a 120% payout ratio with 4 years of growth, supplemented by a 2.4% buyback yield.
Camden Property Trust's current growth trajectory is Stable. The company achieved +1.9% 1Y revenue growth and +136.0% 1Y EPS growth, compared to its 3Y revenue CAGR of +3.4%.
Wall Street consensus is Hold based on 41 analysts, beating EPS expectations in 100% of recent quarters with a 21-quarter streak. The consensus price target represents a +2.7% change from current levels.
Investment risks for Camden Property Trust include: -16.6% 1-year max drawdown, stretched payout ratio. Volatility risk is characterized by a beta of 0.20x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.